Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E O'Reilly

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Molecular Nutrition & Food Research|January 10, 2020
Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein PathwaysMarcella E O'Reilly, Yvonne M Lenighan, Eugene Dillon, et al.
European Journal of Clinical Pharmacology|February 25, 2017
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrelWilliam L Marshall, Hwa-Ping Feng, Luzelena Caro, et al.
Journal of the American Chemical Society|July 26, 2011
Autocatalytic O2 cleavage by an OCO3 trianionic pincer Cr(III) complex: isolation and characterization of the autocatalytic intermediate [Cr(IV)]2(μ-O) dimerMatthew E O'Reilly, Trevor J Del Castillo, Joseph M Falkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.
Cancer Research|February 3, 2006
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktKathryn E O'Reilly, Fredi Rojo, Qing-Bai She, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancerK A Gelmon, S E O'Reilly, A W Tolcher, et al.
The Science of the Total Environment|July 20, 2019
Efficacy of a solar concentrator to Inactivate E. coli and C. perfringens spores in latrine waste in KenyaJ L Murphy, T Ayers, A Foote, et al.
Advances in Radiation Oncology|October 21, 2020
Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose ConstraintsWendy B Harris, Wei Zou, Chingyun Cheng, et al.
European Stroke Journal|April 5, 2021
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysisJ J McCabe, E O'Reilly, S Coveney, et al.
Blood|July 1, 1997
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphomaR D Gascoyne, S A Adomat, S Krajewski, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Molecular Nutrition & Food Research|January 10, 2020
Conjugated Linoleic Acid and Alpha Linolenic Acid Improve Cholesterol Homeostasis in Obesity by Modulating Distinct Hepatic Protein PathwaysMarcella E O'Reilly, Yvonne M Lenighan, Eugene Dillon, et al.
European Journal of Clinical Pharmacology|February 25, 2017
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrelWilliam L Marshall, Hwa-Ping Feng, Luzelena Caro, et al.
Journal of the American Chemical Society|July 26, 2011
Autocatalytic O2 cleavage by an OCO3 trianionic pincer Cr(III) complex: isolation and characterization of the autocatalytic intermediate [Cr(IV)]2(μ-O) dimerMatthew E O'Reilly, Trevor J Del Castillo, Joseph M Falkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeksS Sharma, N Kemeny, G K Schwartz, et al.
Cancer Research|February 3, 2006
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktKathryn E O'Reilly, Fredi Rojo, Qing-Bai She, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancerK A Gelmon, S E O'Reilly, A W Tolcher, et al.
The Science of the Total Environment|July 20, 2019
Efficacy of a solar concentrator to Inactivate E. coli and C. perfringens spores in latrine waste in KenyaJ L Murphy, T Ayers, A Foote, et al.
Advances in Radiation Oncology|October 21, 2020
Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose ConstraintsWendy B Harris, Wei Zou, Chingyun Cheng, et al.
European Stroke Journal|April 5, 2021
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysisJ J McCabe, E O'Reilly, S Coveney, et al.
Blood|July 1, 1997
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphomaR D Gascoyne, S A Adomat, S Krajewski, et al.
Pageof 20